Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deep sedation with remimazolam in radiofrequency catheter ablation of atrial fibrillation
ChiCTR2100048630Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in Atrial fibrillation (AFib) (2 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoint: Adverse respiratory events. Planned start Mar 2021; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on ChiCTR2100048630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100048630.